Lu, R., Jin, Y., & Zheng, M. USP5‐dependent HDAC1 promotes cisplatin resistance and the malignant progression of non–small cell lung cancer by regulating RILP acetylation levels. Wiley.
Chicago Style (17th ed.) CitationLu, Rongguo, Yulin Jin, and Mingfeng Zheng. USP5‐dependent HDAC1 Promotes Cisplatin Resistance and the Malignant Progression of Non–small Cell Lung Cancer by Regulating RILP Acetylation Levels. Wiley.
MLA (9th ed.) CitationLu, Rongguo, et al. USP5‐dependent HDAC1 Promotes Cisplatin Resistance and the Malignant Progression of Non–small Cell Lung Cancer by Regulating RILP Acetylation Levels. Wiley.
Warning: These citations may not always be 100% accurate.